Ondansetron HCl 4 mg in 5 mL Oral Solution
RxNorm 312085
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 312085 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ondansetron HCl 4 mg in 5 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Ondansetron 0.8 mg/ML Oral Solution
(Atom ID: 12340544)
SYPrescribable
Synonym (SY):
Ondansetron (as ondansetron HCl dihydrate) 4 mg per 5 mL Oral Solution
(Atom ID: 8714548)
PTPrescribable
Designated preferred name (PT):
Ondansetron (as ondansetron hydrochloride) 800 microgram/mL oral solution
(Atom ID: 10302580)
SYPrescribable
Synonym (SY):
Ondansetron 4 mg per 5 mL Oral Solution
(Atom ID: 2991148)
PSNPrescribable
Prescribable Name (PSN):
Ondansetron HCl 4 mg in 5 mL Oral Solution
(Atom ID: 8714549)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely ondansetron (as ondansetron hydrochloride) 800 microgram/1 mL conventional release oral solution (clinical drug)
(Atom ID: 10315649)
Patient Education
Ondansetron
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
[Learn More]
* Please review the disclaimer below.